Previous Close | 4.66 |
1-Year Change | -49.51% |
6-Months Change | -30.86% |
3-Months Change | 9.91% |
Moving Avg (50d) | 4.3246 |
Moving Avg (200d) | 7.2413 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.746B |
Beta (3-Years) | 0.54 |
Revenue Growth (ttm) | -12.48% |
Net Profit Margin (ttm) | -0.65% |
Return On Assets (ttm) | -0.63% |
EPS (ttm) | -0.03 |
PE Ratio (ttm) | -155.33 |
Dividend Yield | % |
Asset Description: | Ironwood Pharmaceuticals, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2024-11-06 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
4.567 | 4.427 | 4.334 | 4.194 | 3.961 | 3.728 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.